Physician profile
Ashley Saunders
NPI 1003680117
$1,212.10
in general payments reported to CMS, 2019-2025
18 companies · $615 in 2025
The $615 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.61 · 2024: $514 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.36 | 2024-2025 | |
| Lilly USA, LLC | $256.15 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $151.06 | 2024-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.27 | 2024-2025 | Jardiance, Tradjenta, Synjardy |
| Astrazeneca Pharmaceuticals LP | $50.54 | 2025 | Airsupra |
| Corcept Therapeutics | $44.77 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $36.86 | 2024 | |
| Neurocrine Biosciences, INC. | $25.20 | 2025 | |
| Grifols USA, LLC | $23.20 | 2024 | Prolastin-C Liquid |
| Sanofi Pasteur INC. | $20.23 | 2025 | |
| Morphosys, US INC. | $20.05 | 2023 | Monjuvi |
| Edwards Lifesciences Corporation | $19.17 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $18.86 | 2024 | Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $18.10 | 2025 | Enflonsia, Capvaxive, Gardasil 9 |
| Organon LLC | $18.06 | 2024-2025 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $15.27 | 2024 | Purified Cortrophin Gel |
| Exact Sciences Corporation | $14.27 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $13.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.